Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1 .
Autorzy:
Shaikh AF; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India. KakirdeC; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India. Dhamne C; Homi Bhabha National Institute (HBNI), Mumbai, India.; Pediatric Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Bhanshe P; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India. Joshi S; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India. Chaudhary S; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India. Chatterjee G; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India. Tembhare P; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India. Prasad M; Homi Bhabha National Institute (HBNI), Mumbai, India.; Pediatric Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Roy Moulik N; Homi Bhabha National Institute (HBNI), Mumbai, India.; Pediatric Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Gokarn A; Homi Bhabha National Institute (HBNI), Mumbai, India.; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Bonda A; Homi Bhabha National Institute (HBNI), Mumbai, India.; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Nayak L; Homi Bhabha National Institute (HBNI), Mumbai, India.; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Punatkar S; Homi Bhabha National Institute (HBNI), Mumbai, India.; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Jain H; Homi Bhabha National Institute (HBNI), Mumbai, India.; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Bagal B; Homi Bhabha National Institute (HBNI), Mumbai, India.; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Shetty D; Deparment of Cytogenetics, ACTREC, Tata Memorial Centre, Navi Mumbai, India. Sengar M; Homi Bhabha National Institute (HBNI), Mumbai, India.; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Narula G; Homi Bhabha National Institute (HBNI), Mumbai, India.; Pediatric Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Khattry N; Homi Bhabha National Institute (HBNI), Mumbai, India.; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Banavali S; Homi Bhabha National Institute (HBNI), Mumbai, India.; Pediatric Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India. Gujral S; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India. P G S; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India. Patkar N; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Dec; Vol. 61 (13), pp. 3154-3160. Date of Electronic Publication: 2020 Aug 05.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies